Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,973 | -24,350 | -20,014 | 430,440 | 377,830 |
| Depreciation Amortization | 3,366 | 1,298 | 925 | 442,100 | 493,190 |
| Other Working Capital | 3,278 | -1,250 | 1,849 | 3,360 | -26,950 |
| Other Operating Activity | 4,532 | 1,478 | -71 | -97,910 | -34,940 |
| Operating Cash Flow | $-36,797 | $-22,824 | $-17,311 | $777,990 | $809,130 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -71,330 | -1,997 | N/A | N/A | N/A |
| PPE Investments | -664 | -249 | -644 | -116,250 | -99,290 |
| Net Acquisitions | N/A | N/A | N/A | -148,990 | -20 |
| Other Investing Activity | 0 | 0 | 0 | -14,230 | -52,570 |
| Investing Cash Flow | $-71,994 | $-2,246 | $-644 | $-279,470 | $-151,880 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -1,561 | 5,000 | N/A | N/A |
| Debt Issued | N/A | 5,000 | 10,000 | N/A | N/A |
| Debt Repayment | -2,000 | N/A | -500 | N/A | N/A |
| Common Stock Issued | 77,506 | 72 | 77 | N/A | N/A |
| Other Financing Activity | 72,411 | -999 | 36,160 | -1,082,410 | -627,260 |
| Financing Cash Flow | $147,917 | $2,512 | $50,737 | $-1,082,410 | $-627,260 |
| Exchange Rate Effect | N/A | N/A | N/A | 680 | -4,790 |
| Beginning Cash Position | 13,899 | 36,457 | 3,675 | 838,760 | 813,560 |
| End Cash Position | 53,025 | 13,899 | 36,457 | 255,540 | 838,760 |
| Net Cash Flow | $39,126 | $-22,558 | $32,782 | $-583,210 | $25,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,797 | -22,824 | -17,311 | 777,990 | 809,130 |
| Capital Expenditure | -664 | -249 | -644 | N/A | N/A |
| Free Cash Flow | -37,461 | -23,073 | -17,955 | 777,990 | 809,130 |